| 1 | Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022 | 7.7 | 36 | Citations (PDF) |
| 2 | Measuring healthy life expectancy and determinants of poor perceived health: A population-based study among a subset of rare and common cancer survivors | 2.0 | 2 | Citations (PDF) |
| 3 | Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update | 2.1 | 184 | Citations (PDF) |
| 4 | The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide | 4.3 | 704 | Citations (PDF) |
| 5 | The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis | 22.5 | 27 | Citations (PDF) |
| 6 | Current and future burden of female breast cancer in the Middle East and North Africa region using estimates from GLOBOCAN 2022 | 4.3 | 19 | Citations (PDF) |
| 7 | Global patterns and trends in breast cancer incidence and mortality across 185 countries | 33.0 | 834 | Citations (PDF) |
| 8 | Cancer surveillance in the Eastern Mediterranean region: a 10-year International Agency for Research on Cancer–WHO Regional Office for the Eastern Mediterranean collaboration | 27.4 | 1 | Citations (PDF) |
| 9 | Global burden of cutaneous melanoma incidence attributable to ultraviolet radiation in 2022 | 4.3 | 33 | Citations (PDF) |
| 10 | Global burden of cancer attributable to HIV: a worldwide incidence analysis | 13.3 | 11 | Citations (PDF) |
| 11 | Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan | 3.6 | 11 | Citations (PDF) |
| 12 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | 251.5 | 20,868 | Citations (PDF) |
| 13 | Stage at diagnosis and survival among adult patients with cancer in Rwanda: A population‐based study | 4.3 | 3 | Citations (PDF) |
| 14 | Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019 | 251.5 | 147 | Citations (PDF) |
| 15 | Deciphering the sex gap in global life expectancy: the impact of female-specific cancers 1990-2019 | 4.6 | 9 | Citations (PDF) |
| 16 | Estimated impact of a tobacco-elimination strategy on lung-cancer mortality in 185 countries: a population-based birth-cohort simulation study | 18.7 | 19 | Citations (PDF) |
| 17 | Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A SurvMark‐2 study | 4.3 | 13 | Citations (PDF) |
| 18 | The cost of premature death from cancer attributable to alcohol: Productivity losses in Europe in 2018 | 2.0 | 4 | Citations (PDF) |
| 19 | Discriminatory Ability and Clinical Utility of the AJCC7 and AJCC8 Staging Systems for Breast Cancer in a Middle-Income Setting | 2.8 | 1 | Citations (PDF) |
| 20 | Cancer survival in the northwestern of São Paulo State, Brazil: A population-based study | 2.0 | 7 | Citations (PDF) |
| 21 | Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries | 3.6 | 18 | Citations (PDF) |
| 22 | Lung cancer mortality in the wake of the changing smoking epidemic: a descriptive study of the global burden in 2020 and 2040 | 1.9 | 48 | Citations (PDF) |
| 23 | Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040 | 2.5 | 16 | Citations (PDF) |
| 24 | Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study | 13.3 | 170 | Citations (PDF) |
| 25 | Gains in life expectancy from decreasing cardiovascular disease and cancer mortality – an analysis of 28 European countries 1995–2019 | 5.3 | 15 | Citations (PDF) |
| 26 | The economic impact of cancer mortality among working-age individuals in Brazil from 2001 to 2030 | 2.0 | 10 | Citations (PDF) |
| 27 | A new method of estimating prevalence of childhood cancer survivors (POCCS): example of the 20-year prevalence in The Netherlands | 4.9 | 4 | Citations (PDF) |
| 28 | International burden of cancer deaths and years of life lost from cancer attributable to four major risk factors: a population-based study in Brazil, Russia, India, China, South Africa, the United Kingdom, and United States | 8.2 | 15 | Citations (PDF) |
| 29 | International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study | 5.6 | 57 | Citations (PDF) |
| 30 | Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018 | 4.3 | 35 | Citations (PDF) |
| 31 | Impact of the COVID‐19 pandemic on population‐based cancer registry | 4.3 | 46 | Citations (PDF) |
| 32 | Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population‐based multistate cohort study including 4 618 377 adults in Catalonia, Spain | 4.3 | 31 | Citations (PDF) |
| 33 | Global, regional and national burden of primary liver cancer by subtype | 4.9 | 511 | Citations (PDF) |
| 34 | A way to explore the existence of “immortals” in cancer registry data – An illustration using data from ICBP SURVMARK-2 | 2.0 | 4 | Citations (PDF) |
| 35 | Five ways to improve international comparisons of cancer survival: lessons learned from ICBP SURVMARK-2 | 5.5 | 9 | Citations (PDF) |
| 36 | Cancer Statistics over Time in Northwestern São Paulo State, Brazil: Incidence and Mortality | 1.1 | 11 | Citations (PDF) |
| 37 | Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study | 5.5 | 46 | Citations (PDF) |
| 38 | Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020 | 4.3 | 268 | Citations (PDF) |
| 39 | COVID-19 and Cancer Global Modelling Consortium (CCGMC): A global reference to inform national recovery strategies | 1.4 | 7 | Citations (PDF) |
| 40 | Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach | 3.0 | 19 | Citations (PDF) |
| 41 | Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study | 18.7 | 88 | Citations (PDF) |
| 42 | The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020 | 0.9 | 1,047 | Citations (PDF) |
| 43 | Socio-economic deprivation and cancer incidence in England: Quantifying the role of smoking | 2.3 | 23 | Citations (PDF) |
| 44 | Global burden of primary liver cancer in 2020 and predictions to 2040 | 4.2 | 1,939 | Citations (PDF) |
| 45 | The preventability of cancer in Europe: A quantitative assessment of avoidable cancer cases across 17 cancer sites and 38 countries in 2020 | 4.9 | 16 | Citations (PDF) |
| 46 | Scaling Up the Surveillance of Childhood Cancer: A Global Roadmap | 4.6 | 93 | Citations (PDF) |
| 47 | Colon and rectal cancer survival in seven high-income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project) | 16.8 | 125 | Citations (PDF) |
| 48 | Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050 | 4.3 | 308 | Citations (PDF) |
| 49 | International Trends in Esophageal Squamous Cell Carcinoma and Adenocarcinoma Incidence | 0.7 | 55 | Citations (PDF) |
| 50 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries | 251.5 | 91,221 | Citations (PDF) |
| 51 | Cancer statistics for the year 2020: An overview | 4.3 | 4,970 | Citations (PDF) |
| 52 | Population‐based cancer staging for oesophageal, gastric, and pancreatic cancer 2012‐2014: International Cancer Benchmarking Partnership SurvMark‐2 | 4.3 | 16 | Citations (PDF) |
| 53 | The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non‐small cell lung cancer (ICBP SurvMark‐2 project) | 4.3 | 13 | Citations (PDF) |
| 54 | Impact of tobacco control policies implementation on future lung cancer incidence in Europe: An international, population-based modeling study | 6.9 | 35 | Citations (PDF) |
| 55 | The ever‐increasing importance of cancer as a leading cause of premature death worldwide | 4.0 | 2,262 | Citations (PDF) |
| 56 | Estimated number of cancers attributable to occupational exposures in France in 2017: an update using a new method for improved estimates | 4.0 | 21 | Citations (PDF) |
| 57 | Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study | 27.4 | 577 | Citations (PDF) |
| 58 | Colorectal Cancer in Young and Older Adults in Uruguay: Changes in Recent Incidence and Mortality Trends | 2.9 | 16 | Citations (PDF) |
| 59 | Comparison of liver cancer incidence and survival by subtypes across seven high‐income countries | 4.3 | 42 | Citations (PDF) |
| 60 | Modelling the impact of increased alcohol taxation on alcohol-attributable cancers in the WHO European Region | 6.9 | 17 | Citations (PDF) |
| 61 | Alcohol and Cancer: Epidemiology and Biological Mechanisms | 4.4 | 362 | Citations (PDF) |
| 62 | Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000–19: A pointer to national trajectories towards achieving Sustainable Development goal target 3.4 | 9.5 | 64 | Citations (PDF) |
| 63 | Impact of COVID-19 Pandemic on Cancer-Related Hospitalizations in Brazil | 2.2 | 15 | Citations (PDF) |
| 64 | FROM EARLY TO METASTATIC BREAST CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF DISTANT RECURRENCE RATES | 2.3 | 1 | Citations (PDF) |
| 65 | The influence of birth cohort and calendar period on global trends in ovarian cancer incidence | 4.3 | 72 | Citations (PDF) |
| 66 | Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates | 2.1 | 1,247 | Citations (PDF) |
| 67 | Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends | 4.3 | 79 | Citations (PDF) |
| 68 | Cumulative exposure to premenopausal obesity and risk of postmenopausal cancer: A population‐based study in Icelandic women | 4.3 | 20 | Citations (PDF) |
| 69 | Tobacco-related cancers in Europe: The scale of the epidemic in 2018 | 4.9 | 47 | Citations (PDF) |
| 70 | The world cancer patient population (WCPP): An updated standard for international comparisons of population-based survival | 2.0 | 52 | Citations (PDF) |
| 71 | An innovative method to estimate lifetime prevalence of carcinogenic occupational circumstances: the example of painters and workers of the rubber manufacturing industry in France | 4.0 | 3 | Citations (PDF) |
| 72 | Advances in the methodological approach to friction period estimation: A European perspective | 4.1 | 13 | Citations (PDF) |
| 73 | Global burden of oesophageal and gastric cancer by histology and subsite in 2018 | 16.8 | 530 | Citations (PDF) |
| 74 | Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035 | 16.8 | 432 | Citations (PDF) |
| 75 | Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study | 3.0 | 40 | Citations (PDF) |
| 76 | Collection and Reporting of Indigenous Status Information in Cancer Registries Around the World | 2.1 | 17 | Citations (PDF) |
| 77 | Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study | 5.5 | 19 | Citations (PDF) |
| 78 | Global cancer incidence in older adults, 2012 and 2035: A population‐based study | 4.3 | 584 | Citations (PDF) |
| 79 | Productivity losses associated with premature mortality due to cancer in Russia: A population-wide study covering 2001–2030 | 2.3 | 14 | Citations (PDF) |
| 80 | Global patterns and trends in colorectal cancer incidence in young adults | 16.8 | 795 | Citations (PDF) |
| 81 | Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study | 27.4 | 951 | Citations (PDF) |
| 82 | Essential TNM: a registry tool to reduce gaps in cancer staging information | 27.4 | 123 | Citations (PDF) |
| 83 | Adult Overweight and Survival from Breast and Colorectal Cancer in Swedish Women | 1.1 | 13 | Citations (PDF) |
| 84 | Cancers in France in 2015 attributable to insufficient physical activity | 2.0 | 7 | Citations (PDF) |
| 85 | Does Alcohol Use Affect Cancer Risk? | 4.8 | 27 | Citations (PDF) |
| 86 | Aging and the cancer burden in Latin America and the Caribbean: Time to act | 1.8 | 27 | Citations (PDF) |
| 87 | Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study | 27.4 | 438 | Citations (PDF) |
| 88 | Population Perception and Estimated Contribution of Lifestyle and Environmental Factors on the National Burden of Cancer in France | 0.3 | 0 | Citations (PDF) |
| 89 | International trends in COPD mortality, 1995–2017 | 8.7 | 68 | Citations (PDF) |
| 90 | Cancers in France in 2015 attributable to occupational exposures | 4.4 | 61 | Citations (PDF) |
| 91 | Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report | 16.8 | 158 | Citations (PDF) |
| 92 | The risk of cancer attributable to diagnostic medical radiation: Estimation for France in 2015 | 4.3 | 46 | Citations (PDF) |
| 93 | Global trends in colorectal cancer mortality: projections to the year 2035 | 4.3 | 481 | Citations (PDF) |
| 94 | Cancer incidence in older adults in selected regions of sub‐Saharan Africa, 2008–2012 | 4.3 | 21 | Citations (PDF) |
| 95 | The impact of historical breastfeeding practices on the incidence of cancer in France in 2015 | 1.7 | 5 | Citations (PDF) |
| 96 | Tobacco‐attributable burden of cancer according to socioeconomic position in France | 4.3 | 22 | Citations (PDF) |
| 97 | Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012 | 4.3 | 175 | Citations (PDF) |
| 98 | Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): A population-based comparison | 2.0 | 116 | Citations (PDF) |
| 99 | The Future Burden of Colorectal Cancer Among US Blacks and Whites | 4.6 | 18 | Citations (PDF) |
| 100 | Epidemiological patterns of leukaemia in 184 countries: a population-based study | 9.5 | 246 | Citations (PDF) |
| 101 | The global cancer burden and human development: A review | 2.3 | 230 | Citations (PDF) |
| 102 | Status of implementation and organization of cancer screening in The European Union Member States—Summary results from the second European screening report | 4.3 | 220 | Citations (PDF) |
| 103 | Cancers in France in 2015 attributable to high body mass index | 2.0 | 27 | Citations (PDF) |
| 104 | Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States | 251.5 | 1,332 | Citations (PDF) |
| 105 | Effect on longevity of one-third reduction in premature mortality from non-communicable diseases by 2030: a global analysis of the Sustainable Development Goal health target | 13.3 | 153 | Citations (PDF) |
| 106 | Cancers related to lifestyle and environmental factors in France in 2015 | 4.9 | 81 | Citations (PDF) |
| 107 | Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind | 1.4 | 52 | Citations (PDF) |
| 108 | The fraction of lung cancer incidence attributable to fine particulate air pollution in France: Impact of spatial resolution of air pollution models | 10.2 | 36 | Citations (PDF) |
| 109 | Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | 251.5 | 71,759 | Citations (PDF) |
| 110 | Cancers attributable to tobacco smoking in France in 2015 | 0.3 | 35 | Citations (PDF) |
| 111 | Occupational exposures and cancer: a review of agents and relative risk estimates | 2.8 | 65 | Citations (PDF) |
| 112 | Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018 | 4.9 | 2,194 | Citations (PDF) |
| 113 | Cancers of the brain and CNS: global patterns and trends in incidence | 1.0 | 102 | Citations (PDF) |
| 114 | Global patterns and trends in colorectal cancer incidence and mortality | 16.8 | 4,541 | Citations (PDF) |
| 115 | Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends | 2.1 | 2,223 | Citations (PDF) |
| 116 | Assessing global transitions in human development and colorectal cancer incidence | 4.3 | 47 | Citations (PDF) |
| 117 | Profile of cancer in the Eastern Mediterranean region: The need for action | 2.0 | 73 | Citations (PDF) |
| 118 | Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study | 27.4 | 523 | Citations (PDF) |
| 119 | The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012 | 251.5 | 623 | Citations (PDF) |
| 120 | Cohort profile: a nationwide cohort of Finnish military recruits born in 1958 to study the impact of lifestyle factors in early adulthood on disease outcomes | 1.9 | 3 | Citations (PDF) |
| 121 | New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis | 5.3 | 45 | Citations (PDF) |
| 122 | An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence | 2.0 | 98 | Citations (PDF) |
| 123 | Alcohol Use and Breast Cancer: A Critical Review | 2.5 | 167 | Citations (PDF) |
| 124 | Burden of Cancer in a Large Consortium of Prospective Cohorts in Europe | 4.6 | 24 | Citations (PDF) |
| 125 | Prostate cancer burden in Central and South America | 2.0 | 40 | Citations (PDF) |
| 126 | U.S. Burden of Cancer by Race and Ethnicity According to Disability-Adjusted Life Years | 3.2 | 32 | Citations (PDF) |
| 127 | Cancer patterns and trends in Central and South America | 2.0 | 82 | Citations (PDF) |
| 128 | Thyroid cancer burden in Central and South America | 2.0 | 25 | Citations (PDF) |
| 129 | Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex | 1.1 | 18 | Citations (PDF) |
| 130 | Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection | 3.2 | 51 | Citations (PDF) |
| 131 | A global view on cancer incidence and national levels of the human development index | 4.3 | 275 | Citations (PDF) |
| 132 | Inequalities in cancer incidence and mortality across medium to highly developed countries in the twenty-first century | 1.7 | 19 | Citations (PDF) |
| 133 | Obesity and cancer: An update of the global impact | 2.0 | 266 | Citations (PDF) |
| 134 | Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer‐related mortality in Europe | 4.3 | 148 | Citations (PDF) |
| 135 | Global burden of cancer attributable to high body-mass index in 2012: a population-based study | 27.4 | 858 | Citations (PDF) |
| 136 | Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory | 4.9 | 444 | Citations (PDF) |
| 137 | Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988–2010 | 4.9 | 153 | Citations (PDF) |
| 138 | Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 | 4.3 | 25,398 | Citations (PDF) |
| 139 | Breast cancer diagnosis, patterns of care and burden of disease in Queensland, Australia (1998–2004): does being Indigenous make a difference? | 1.8 | 16 | Citations (PDF) |
| 140 | Urban greenways have the potential to increase physical activity levels cost-effectively | 0.3 | 66 | Citations (PDF) |
| 141 | The ban on phenacetin is associated with changes in the incidence trends of upper‐urinary tract cancers in Australia | 1.6 | 9 | Citations (PDF) |
| 142 | Second primary cancers in survivors of cervical cancer in the Netherlands: Implications for prevention and surveillance | 2.0 | 53 | Citations (PDF) |
| 143 | Trends in the risks of melanoma as a second primary cancer among cancer patients in the Netherlands, 1989–2008 | 1.5 | 4 | Citations (PDF) |
| 144 | Kaposi sarcoma trends in Uganda and Zimbabwe: A sustained decline in incidence? | 4.3 | 22 | Citations (PDF) |
| 145 | Second Primary Cancers in Subsites of Colon and Rectum in Patients With Previous Colorectal Cancer | 1.7 | 41 | Citations (PDF) |
| 146 | Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions | 62.1 | 549 | Citations (PDF) |
| 147 | Most colorectal cancer survivors live a large proportion of their remaining life in good health | 1.7 | 37 | Citations (PDF) |
| 148 | Global Burden of Human Papillomavirus and Related Diseases | 3.1 | 1,449 | Citations (PDF) |
| 149 | Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer | 2.5 | 81 | Citations (PDF) |
| 150 | High Incidence of a Second Primary Esophageal Squamous Cell Carcinoma in Patients With Previous Head-and-Neck Cancer: A Nationwide Population-Based Study | 0.9 | 2 | Citations (PDF) |
| 151 | Reducing inequalities in lung cancer incidence through smoking policies | 2.6 | 21 | Citations (PDF) |
| 152 | Prevalence of multiple malignancies in the Netherlands in 2007 | 4.3 | 47 | Citations (PDF) |
| 153 | Incident cancer burden attributable to excess body mass index in 30 European countries | 4.3 | 253 | Citations (PDF) |
| 154 | Explanations for worsening cancer survival | 70.7 | 25 | Citations (PDF) |
| 155 | Author reply: A further caveat in interpreting cancer survival | 70.7 | 1 | Citations (PDF) |
| 156 | Increased consumption of fruit and vegetables and future cancer incidence in selected European countries | 4.9 | 107 | Citations (PDF) |
| 157 | Scenarios of future lung cancer incidence by educational level: Modelling study in Denmark | 4.9 | 18 | Citations (PDF) |
| 158 | The long road towards cancer prevention: 4 steps backward and 8 forward | 4.9 | 13 | Citations (PDF) |
| 159 | Impact of a smoking and alcohol intervention programme on lung and breast cancer incidence in Denmark: An example of dynamic modelling with Prevent | 4.9 | 62 | Citations (PDF) |
| 160 | Interpreting the epidemiological evidence linking obesity and cancer: A framework for population-attributable risk estimations in Europe | 4.9 | 91 | Citations (PDF) |
| 161 | Multiple tumours in survival estimates | 4.9 | 133 | Citations (PDF) |
| 162 | Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s | 4.9 | 664 | Citations (PDF) |
| 163 | Cancer causes and prevention: A condensed appraisal in Europe in 2008 | 4.9 | 46 | Citations (PDF) |
| 164 | Does the Decrease in Hormone Replacement Therapy Also Affect Breast Cancer Risk in the Netherlands? | 16.9 | 48 | Citations (PDF) |
| 165 | Decreased Risk of Prostate Cancer after Skin Cancer Diagnosis: A Protective Role of Ultraviolet Radiation? | 3.3 | 80 | Citations (PDF) |
| 166 | Excess of cancers in Europe: A study of eleven major cancers amenable to lifestyle change | 4.3 | 70 | Citations (PDF) |
| 167 | Should women be advised to have first childbirth at age <20 years to reduce breast cancer risk? | 2.3 | 1 | Citations (PDF) |
| 168 | An overview of prognostic factors for long-term survivors of breast cancer | 2.3 | 447 | Citations (PDF) |
| 169 | On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk | 2.3 | 45 | Citations (PDF) |
| 170 | Benchmarking life expectancy and cancer mortality: global comparison with cardiovascular disease 1981-2010 | 0.2 | 63 | Citations (PDF) |
| 171 | Pancreatic cancer: an increasing global public health concernGut, 0, , gutjnl-2021-326311 | 16.8 | 22 | Citations (PDF) |
| 172 | Climate change mitigation and synergies with primary cancer prevention in Europe: time to implement opportunities | 4.6 | 3 | Citations (PDF) |
| 173 | Childhood cancer survival in Africa, Asia, Latin America and the Caribbean, during 2008-2017 (SURVCAN-3): a population-based benchmarking study of 16 821 children | 4.6 | 5 | Citations (PDF) |
| 174 | Regional inequalities in mortality from colorectal cancer and its indirect economic impact in Brazil from 2001 to 2030: a human capital approach study | 2.8 | 0 | Citations (PDF) |
| 175 | The direct costs of cancer care: a review of recent trends and variations in 39 countries | 1.7 | 0 | Citations (PDF) |
| 176 | Stat Bite: Cancer cases attributable to modifiable risk factors in Europe and Sub-Saharan Africa in 2022 | 4.6 | 0 | Citations (PDF) |
| 177 | GLOBOCAN 2022 cancer incidence in populations affected by crises: a global mapping and analysis | 8.2 | 0 | Citations (PDF) |
| 178 | Global Cancer Prevention: Current Approaches and Future Directions | 4.4 | 0 | Citations (PDF) |
| 179 | Quantifying the potential of alcohol policies for cancer prevention in the EU: a modelling study | 6.9 | 0 | Citations (PDF) |
